참고문헌
- El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817-823. https://doi.org/10.7326/0003-4819-139-10-200311180-00009
- Kojiro M. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol 2005;19:39-62 https://doi.org/10.1016/j.bpg.2004.10.007
- Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992;183:819-825 https://doi.org/10.1148/radiology.183.3.1316622
- Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 2009;250:435-443 https://doi.org/10.1148/radiol.2501071702
- Organ Procurement and Transplantation Network. OPTN/UNOS policy 9.3.G.iv. Available at: http://optn.transplant. hrsa.gov/ContentDocuments/OPTN_Policies.pdfnameddest=Policy_09. Published Jan 1, 2015. Accessed Mar 16, 2016
- Liver Reporting and Data System, version 2013.1. American College of Radiology Available at: http://www.acr.org/ Quality-Safety/Resources/LIRADS/. Accessed Mar 16, 2016
- Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, et al. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre-treatment findings. World J Gastroenterol 2007;13:6022-6026 https://doi.org/10.3748/wjg.v13.45.6022
- Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992;70:45-49 https://doi.org/10.1002/1097-0142(19920701)70:1<45::AID-CNCR2820700108>3.0.CO;2-7
- Grazioli L, Olivetti L, Fugazzola C, Benetti A, Stanga C, Dettori E, et al. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 1999;9:62-67 https://doi.org/10.1007/s003300050629
- Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 2014;273:30-50 https://doi.org/10.1148/radiol.14132362
- Dioguardi Burgio M, Picone D, Cabibbo G, Midiri M, Lagalla R, Brancatelli G. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine. Abdom Radiol (NY) 2016;41:1546-1554 https://doi.org/10.1007/s00261-016-0726-7
- Hope TA, Fowler KJ, Sirlin CB, Costa EA, Yee J, Yeh BM, et al. Hepatobiliary agents and their role in LI-RADS. Abdom Imaging 2015;40:613-625 https://doi.org/10.1007/s00261-014-0227-5
- Yu JS, Kim YH, Rofsky NM. Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images. J Comput Assist Tomogr 2005;29:51-58 https://doi.org/10.1097/01.rct.0000152846.06095.b3
- Yu JS, Rofsky NM. Dynamic subtraction MR imaging of the liver: advantages and pitfalls. AJR Am J Roentgenol 2003;180:1351-1357 https://doi.org/10.2214/ajr.180.5.1801351
- Secil M, Obuz F, Altay C, Gencel O, Igci E, Sagol O, et al. The role of dynamic subtraction MRI in detection of hepatocellular carcinoma. Diagn Interv Radiol 2008;14:200-204
- Sundarakumar DK, Wilson GJ, Osman SF, Zaidi SF, Maki JH. Evaluation of image registration in subtracted 3D dynamic contrast-enhanced MRI of treated hepatocellular carcinoma. AJR Am J Roentgenol 2015;204:287-296 https://doi.org/10.2214/AJR.13.12417
- Cho ES, Choi JY. MRI features of hepatocellular carcinoma related to biologic behavior. Korean J Radiol 2015;16:449-464 https://doi.org/10.3348/kjr.2015.16.3.449
- Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Fujita N, et al. Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI. Diagn Interv Radiol 2015;21:96-104 https://doi.org/10.5152/dir.2014.13013
- Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging 2010;32:360-366 https://doi.org/10.1002/jmri.22271
- Park HJ, Jang KM, Kang TW, Song KD, Kim SH, Kim YK, et al. Identification of imaging predictors discriminating different primary liver tumours in patients with chronic liver disease on gadoxetic acid-enhanced MRI: a classification tree analysis. Eur Radiol 2016;26:3102-3111 https://doi.org/10.1007/s00330-015-4136-y
-
Rimola J, Forner A, Tremosini S, Reig M, Vilana R, Bianchi L, et al. Non-invasive diagnosis of hepatocellular carcinoma
$\leq$ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 2012;56:1317-1323 https://doi.org/10.1016/j.jhep.2012.01.004 - Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. AJR Am J Roentgenol 2011;197:W44-W52 https://doi.org/10.2214/AJR.10.5845
- Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67 https://doi.org/10.1148/radiology.200.1.8657946
- An C, Rhee H, Han K, Choi JY, Park YN, Park MS, et al. Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma. Eur Radiol 2017;27:2610-2618 https://doi.org/10.1007/s00330-016-4634-6
피인용 문헌
- Evaluation of Primary Liver Cancers Using Hepatocyte‐Specific Contrast‐Enhanced MRI: Pitfalls and Potential Tips vol.53, pp.3, 2018, https://doi.org/10.1002/jmri.27213